The discovery and development of HMG-CoA reductase inhibitors.

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906

All ras proteins are polyisoprenylated but only some are palmitoylated

Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630

Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.

(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954

Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity

Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

Influence of nicotinic acid on serum cholesterol in man

Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726

NK-104: a novel synthetic HMG-CoA reductase inhibitor

Kajinami, K., Mabuchi, H., & Saito, Y. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2653 · Cited by 85

Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus Cells

Tu, J., Li, W., Zhang, Y., Wu, X., Song, Y., Kang, L., Liu, W., Wang, K., Li, S., Hua, W., et al. (2017) · Inflammation · doi:10.1007/s10753-017-0516-6 · Cited by 84

Reactive oxygen species regulate lovastatin biosynthesis in Aspergillus terreus during submerged and solid-state fermentations

Miranda, R. U., Gómez-Quiroz, L. E., Mendoza, M. V., Pérez-Sánchez, A., Fierro, F., & Barrios-González, J. (2014) · Fungal Biology · doi:10.1016/j.funbio.2014.09.002 · Cited by 83

Human Genetics of Obesity and Type 2 Diabetes Mellitus

Ingelsson, E., & McCarthy, M. I. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002090 · Cited by 86

Trypanosoma cruzi Response to Sterol Biosynthesis Inhibitors: Morphophysiological Alterations Leading to Cell Death

Kessler, R. L., Soares, M. J., Probst, C., & Krieger, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055497 · Cited by 80

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing

Shrivastava-Ranjan, P., Flint, M., Bergeron, É., McElroy, A. K., Chatterjee, P., Albariño, C. G., Nichol, S. T., & Spiropoulou, C. F. (2018) · mBio · doi:10.1128/mbio.00660-18 · Cited by 80

Hempseed Peptides Exert Hypocholesterolemic Effects with a Statin-Like Mechanism

Zanoni, C., Aiello, G., Arnoldi, A., & Lammi, C. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02742 · Cited by 86

Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy

Buemi, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.105330 · Cited by 78

Cardiology: the past, the present, and the future

Braunwald, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.025 · Cited by 74

Relative Induction of mRNA for HMG CoA Reductase and LDL Receptor by Five Different HMG-CoA Reductase Inhibitors in Cultured Human Cells

Morikawa, S., Umetani, M., Nakagawa, S., Yamazaki, H., Suganami, H., Inoue, K., Kitahara, M., Hamakubo, T., Kodama, T., & Saitō, Y. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.138 · Cited by 76

A Genome Wide Association Study Identifies Common Variants Associated with Lipid Levels in the Chinese Population

Zhou, L., He, M., Mo, Z., Wu, C. H., Yang, H., Yu, D., Yang, X., Zhang, X., Wang, Y., Sun, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082420 · Cited by 76

Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies

Baassiri, M. G. E., Raouf, Z., Badin, S., Escobosa, A., Sodhi, C. P., & Nasr, I. W. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03118-3 · Cited by 81

Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury

Jones, M. K., Itani, R. M., Wang, H., Tomikawa, M., Sarfeh, I. J., Szabó, S., & Tarnawski, A. S. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1345 · Cited by 75

Statins—From Fungi to Pharmacy

Sadowska, A. J., Osiński, P., Roztocka, A., Kaczmarz-Chojnacka, K., Zapora, E., Sawicka, D., & Car, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010466 · Cited by 83

Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites

Sunazuka, T., & Ōmura, S. (2005) · Chemical Reviews · doi:10.1021/cr040628i · Cited by 74

Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/β-Catenin Signaling

Robin, N. C., Agoston, Z., Biechele, T. L., James, R. G., Berndt, J. D., & Moon, R. T. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.002 · Cited by 73

Protein arginine methyltransferase 5 promotes cholesterol biosynthesis–mediated Th17 responses and autoimmunity

Webb, L., Sengupta, S., Edell, C., Piedra-Quintero, Z. L., Amici, S. A., Miranda, J. N., Bevins, M. R., Kennemer, A. A., Laliotis, G., Tsichlis, P. N., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131254 · Cited by 72

Pleiotropic use of Statins as non-lipid-lowering drugs

Zhang, Q., Dong, J., & Yu, Z. Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42965 · Cited by 78

Influence of elevated ambient temperature upon some physiological measurements of New Zealand White rabbits

Ondruška, Ľ., Rafay, J., Okab, A. B., Ayoub, M. A., Al-Haidary, A. A., Samara, E. M., Parkanyi, V., Chrastinová, Ľ., Jurčí­k, R., Massányi, P., et al. (2011) · Veterinární Medicína · doi:10.17221/3150-vetmed · Cited by 73

The pharmacological exploitation of cholesterol 7α-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol

Gilardi, F., Mitro, N., Godio, C., Scotti, E., Caruso, D., Crestani, M., & Fabiani, E. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.003 · Cited by 72

Lipid-Lowering Drugs in the Management of Hyperlipidaemia

Bhatnagar, D. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00018-7 · Cited by 74

A novel lipoprotein-mediated mechanism controlling sexual attractiveness in a colorful songbird

McGraw, K. J., & Parker, R. S. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.09.001 · Cited by 71

Negative regulation of plastidial isoprenoid pathway by herbivore-induced β-cyclocitral in Arabidopsis thaliana

Mitra, S., Estrada‐Tejedor, R., Volke, D. C., Phillips, M. A., Gershenzon, J., & Wright, L. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008747118 · Cited by 70

Metabolic modes of action of the statins in the hyperlipoproteinemias

Aguilar-Salinas, C. A., Barrett, P. H. R., & Schonfeld, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00198-1 · Cited by 70

Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig

Conde, K., Vergara-Jiménez, M. D. J., Krause, B. R., Newton, R. S., & Fernández, M. L. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37486-1 · Cited by 70

Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis

Rojo‐Arreola, L., Long, T., Asarnow, D. E., Suzuki, B. M., Singh, R., & Caffrey, C. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087594 · Cited by 72

Rab‐small GTPases are involved in fluvastatin and pravastatin‐induced vacuolation in rat skeletal myofibers

Sakamoto, K., Honda, T., Yokoya, S., Waguri, S., & Kimura, J. (2007) · The FASEB Journal · doi:10.1096/fj.07-8713com · Cited by 69

Competition between a sterol biosynthetic enzyme and tRNA modification in addition to changes in the protein synthesis machinery causes altered nonsense suppression

Benko, A. L., Vaduva, G., Martín, N. C. R., & Hopper, A. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.61 · Cited by 69

HMG-CoA reductase inhibitors

Endo, A., & Hasumi, K. (1993) · Natural Product Reports · doi:10.1039/np9931000541 · Cited by 68

Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia

Kajinami, K., Koizumi, J., Ueda, K., Miyamoto, S., Takegoshi, T., & Mabuchi, H. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00656-6 · Cited by 68

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity

Ness, G. C., Chambers, C. M., & Lopez, D. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34205-x · Cited by 66

Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort

Lai, C., Lee, M.-T. G., Lee, S.-H., Hsu, W., Chang, S.-S., Chen, S., & Lee, C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207052 · Cited by 63

Atheroma Progression in Hyporesponders to Statin Therapy

Kataoka, Y., John, J. S., Wolski, K., Uno, K., Puri, R., Tuzcu, E. M., Nissen, S. E., & Nicholls, S. J. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304477 · Cited by 64

Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate

Ooi, T. C., Heinonen, T. M., Alaupovic, P., Davignon, J., Leiter, L. A., Lupien, P. J., Sniderman, A. D., Tan, M. H., Tremblay, G., Sorisky, A., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1793 · Cited by 64

Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver

Tang, B.-K., & KALOW, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00196860 · Cited by 63

Effect of Statins on Metabolism of Apo-B–Containing Lipoproteins in Hypertriglyceridemic Men

Vega, G. L., & Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00036-8 · Cited by 63

Inhibition of Angiotensin-1-Converting Enzyme Activity by Two Varieties of Ginger ( Zingiber officinale ) in Rats Fed a High Cholesterol Diet

Akinyemi, A. J., Ademiluyi, A. O., & Oboh, G. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0264 · Cited by 62

Effect of statin drugs and aspirin on progression in open‐angle glaucoma suspects using confocal scanning laser ophthalmoscopy

Castro, D. K. D., Punjabi, O. S., Bostrom, A., Stamper, R. L., Lietman, T. M., Ray, K. J., & Lin, S. C. (2007) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2007.01529.x · Cited by 61

Five Questions about Non-Mevalonate Isoprenoid Biosynthesis

Odom, A. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002323 · Cited by 59

Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking

Ojha, S. K., Islam, B., Charu, C., Adem, A., & Aburawi, E. H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86705 · Cited by 63

Lovastatin Induces Neuroprotection Through Tumor Necrosis Factor Receptor 2 Signaling Pathways

Dolga, A. M., Nijholt, I. M., Ostroveanu, A., ten Bosch, Q. A., Luiten, P. G. M., & Eisel, U. L. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13201 · Cited by 61

Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson’s disease

Kang, S. Y., Lee, S.-B., Kim, H., Kim, H.-T., Yang, H. O., & Jang, W. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.063 · Cited by 60

Select 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Vary in Their Ability to Reduce Egg Yolk Cholesterol Levels in Laying Hens through Alteration of Hepatic Cholesterol Biosynthesis and Plasma VLDL Composition

Elkin, R. G., Yan, Z., Yuan, Ž., Donkin, S. S., Buhman, K. K., Story, J. A., Turek, J. J., Porter, R. E., Anderson, M. K., Homan, R., et al. (1999) · Journal of Nutrition · doi:10.1093/jn/129.5.1010 · Cited by 60

Protective effect of atorvastatin in cultured osteoarthritic chondrocytes

Simopoulou, T., Malizos, Κ. Ν., Poultsides, L. A., & Tsezou, A. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20953 · Cited by 59

The Mevalonate Pathway ofStaphylococcus aureus

Balibar, C. J., Shen, X., & Tao, J. (2008) · Journal of Bacteriology · doi:10.1128/jb.01357-08 · Cited by 59

Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait

Iqbal, D., Khan, M. S., Khan, M. S., Ahmad, S., Hussain, M. S., & Ali, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0013-6 · Cited by 59

Serendipity in Cancer Drug Discovery: Rational or Coincidence?

Prasad, S., Gupta, S. C., & Aggarwal, B. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.004 · Cited by 59

The Role of Statins in Vascular Disease

Laws, P. E., Spark, J. I., Cowled, P., & Fitridge, R. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2003.09.014 · Cited by 59

Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin

Arca, M. (1994) · JAMA · doi:10.1001/jama.271.6.453 · Cited by 59

3-hydroxy-3-methylglutaryl–coenzyme a reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats

Hooiveld, G. J. E. J., Vos, T. A., Scheffer, G. L., van Goor, H., Koning, H., Bloks, V. W., Loot, A. E., Meijer, D. K. F., Jansen, P. L. M., Kuipers, F., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70462-2 · Cited by 59

Lipid metabolism disorder promotes the development of intervertebral disc degeneration

Yi, J., Zhou, Q., Huang, J., Niu, S., Ji, G., & Zheng, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115401 · Cited by 58

Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering

Haslinger, B., Goedde, M. F., Toet, K. H., & Kooistra, T. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00601.x · Cited by 58

Pharmacogenomics of Statin Responsiveness

Kajinami, K., Akao, H., Polisecki, E. Y., & Schaefer, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.011 · Cited by 58

Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening

Shiuan, D., Lin, S., Hwang, K.-J., & Weng, C. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s84641 · Cited by 57

3-Hydroxy-3-methyl-glutaryl-CoA Reductase inTrypanosoma(Schizotrypanum)cruzi:Subcellular Localization and Kinetic Properties

Concepción, J. L., González‐Pacanowska, D., & Urbina, J. A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0577 · Cited by 57

Mechanism of action of anti-hypercholesterolemia drugs and their resistance

Tiwari, V., & Khokhar, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.048 · Cited by 60

Unlocking longevity: the role of telomeres and its targeting interventions

Schellnegger, M., Hofmann, E., Carnieletto, M., & Kamolz, L. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1339317 · Cited by 65

Lipidomics for Geochemistry

Pearson, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-095975-7.01022-6 · Cited by 55

Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes

Isusi, E., Aspichueta, P., Liza, M., Hernández, M., Dı́az-Jullien, C., Hernández, G., Martínez, M. J., & Ochoa, B. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00407-x · Cited by 55

Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: Implications for treatment

Nagenborg, J., Goossens, P., Biessen, E. A. L., & Donners, M. M. P. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.005 · Cited by 50

Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity

Miller, T., Yang, F., Wise, C., Meng, F., Priester, S., Munshi, M. K., Guerrier, M., Dostal, D. E., & Glaser, S. S. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.01.010 · Cited by 54

A Highly Productive, Whole-Cell DERA Chemoenzymatic Process for Production of Key Lactonized Side-Chain Intermediates in Statin Synthesis

Ošlaj, M., Cluzeau, J., Orkić, D., Kopitar, G., Mrak, P., & Časar, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062250 · Cited by 57

Aspergillus terreus as an industrial filamentous fungus for pharmaceutical biotechnology

Huang, X., Men, P., Tang, S., & Lu, X. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.02.004 · Cited by 54

The Low Density Lipoprotein Receptor Prevents Secretion of Dense ApoB100-containing Lipoproteins from the Liver

Larsson, S. L., Skogsberg, J., & Björkegren, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m303057200 · Cited by 54

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

Alaupovic, P., Heinonen, T. M., Shurzinske, L., & Black, D. M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00119-6 · Cited by 54

The role of statins in clinical medicine -LDL - cholesterol lowering and beyond

Rutishauser, J. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11170 · Cited by 53

Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres

Sakamoto, K., Mikami, H., & Kimura, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.192 · Cited by 53

Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow

Eccles, K. A., Sowden, H., Porter, K. E., Parkin, S. M., Homer‐Vanniasinkam, S., & Graham, A. M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.018 · Cited by 53

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study

de Keyser, C. E., Peters, B. J. M., Becker, M. L., Visser, L. E., Uitterlinden, A. G., Klungel, O. H., Verstuyft, C., Albert Hofman, D., der Zee, A. H. M., & Stricker, B. H. C. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000018 · Cited by 53

Molecular pathways and agents for lowering LDL-cholesterol in addition to statins

Costet, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.006 · Cited by 55

The Medicinal Chemistry of Liver X Receptor (LXR) Modulators

Tice, C. M., Noto, P. B., Fan, K. Y., Zhuang, L., Lala, D. S., & Singh, S. B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500442z · Cited by 56

Daio-Orengedokuto Inhibits HMG-CoA Reductase and Pancreatic Lipase.

Kim, Y. S., Jung, E.-A., Shin, J., Chang, J.-C., Yang, H.-K., Kim, N., Cho, K., Bae, H.-S., Moon, S., & Kim, D. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1442 · Cited by 53

Design of a highly potent inhibitory peptide acting as a competitive inhibitor of HMG-CoA reductase

Pak, V. V., Koo, M., Kwon, D. Y., & Yun, L. M. (2012) · Amino Acids · doi:10.1007/s00726-012-1276-0 · Cited by 52

Effect of Levels of Acetate on the Mevalonate Pathway of Borrelia burgdorferi

Laar, T. A. V., Lin, Y.-H., Miller, C. L., Karna, S. L. R., Chambers, J. P., & Seshu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038171 · Cited by 50

Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage

Castanares‐Zapatero, D., & Hantson, P. E. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-12 · Cited by 51

Catalysis by Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proposed roles of histidine 865, glutamate 558, and aspartate 766

Frimpong, K., & Rodwell, V. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78148-4 · Cited by 51

Histologic and Ultrastructural Study on Statin Graft in Rabbit Skulls

Wong, R., & Rabie, A. B. M. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.06.009 · Cited by 51

Reducing shell egg cholesterol content. II. Review of approaches utilizing non-nutritive dietary factors or pharmacological agents and an examination of emerging strategies

Elkin, R. G. (2007) · World s Poultry Science Journal · doi:10.1017/s0043933907001249 · Cited by 50

Human isoprenoid synthase enzymes as therapeutic targets

Park, J., Matralis, A. N., Berghuis, A. M., & Tsantrizos, Y. S. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00050 · Cited by 50

Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity

Pazzucconi, F., Dorigotti, F., Gianfranceschi, G., Campagnoli, G., Sirtori, M., Franceschini, G., & Sirtori, C. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05571-d · Cited by 50

Prospects for rational approaches to anthelmintic discovery

Thompson, D. P., Klein, R. D., & Geary, T. G. (1996) · Parasitology · doi:10.1017/s0031182000077994 · Cited by 50

Cholesterol and Coronary Heart Disease

Grundy, S. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320055006 · Cited by 50

Penicillin and cephalosporin biosyntheses are also regulated by reactive oxygen species

Bibián-León, M. E., Pérez-Sánchez, A., Mejía, A., & Barrios-González, J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10330-2 · Cited by 49

Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis

Guler, R., Ozturk, M., Sabeel, S., Motaung, B., Parihar, S. P., Thienemann, F., & Brombacher, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733853 · Cited by 46

Effect of Statins on the Nanomechanical Properties of Supported Lipid Bilayers

Redondo‐Morata, L., Sanford, R. L., Andersen, O. S., & Scheuring, S. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.06.016 · Cited by 52

Migraine polygenic risk score associates with efficacy of migraine-specific drugs

Kogelman, L. J. A., Esserlind, A.-L., Christensen, A. F., Awasthi, S., Ripke, S., Ingason, A., Davidsson, O. B., Erikstrup, C., Hjalgrim, H., Ullum, H., et al. (2019) · Neurology Genetics · doi:10.1212/nxg.0000000000000364 · Cited by 49

Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents

Cai, Z., Zhou, W., & Sun, L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.044 · Cited by 48

Streamlined Catalytic Asymmetric Synthesis of Atorvastatin

Kawato, Y., Chaudhary, S., Kumagai, N., & Shibasaki, M. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201204609 · Cited by 47

Effects of Farnesyl Pyrophosphate Accumulation on Calvarial Osteoblast Differentiation

Weivoda, M. M., & Hohl, R. J. (2011) · Endocrinology · doi:10.1210/en.2011-0016 · Cited by 47

Present and future therapeutic strategies in non-alcoholic fatty liver disease

Calamita, G., & Portincasa, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1231 · Cited by 47

The pharmacogenomics of statins

Gelissen, I. C., & McLachlan, A. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.002 · Cited by 47

Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution

Ishitsuka, R., Saito, T., Osada, H., Ohno-Iwashita, Y., & Kobayashi, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d018184 · Cited by 51

Statins Could Be Used to Control Replication of Some Viruses, Including HIV-1

Gilbert, C., Bergeron, M., Méthot, S., Giguère, J.-F., & Tremblay, M. J. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.474 · Cited by 47

Pravastatin Prevents Arrhythmias Induced by Coronary Artery Ischemia/Reperfusion in Anesthetized Normocholesterolemic Rats

Chen, J., Nagasawa, Y., Zhu, B., Ohmori, M., Harada, K.-I., Fujimura, A., & Hashimoto, K. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.93.87 · Cited by 47

What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?

Thompson, G. R. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06084-x · Cited by 47

Phenolic compounds from sandpaper (ficus exasperata) leaf inhibits angiotensin 1 converting enzyme in high cholesterol diet fed rats

Oboh, G., Akinyemi, A. J., Osanyinlusi, F. R., Ademiluyi, A. O., Boligon, A. A., & Athayde, M. L. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.09.029 · Cited by 46

Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation

Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46

Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol

Alvarez, M. I., Glover, L. C., Luo, P. M., Wang, L., Theusch, E., Oehlers, S. H., Walton, E. M., Tram, T. T. B., Kuang, Y., Rotter, J. I., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706070114 · Cited by 44

Chemotherapy for Fighting Schistosomiasis: Past, Present and Future

Mäder, P., Rennar, G. A., Ventura, A. M. P., Grevelding, C. G., & Schlitzer, M. (2018) · ChemMedChem · doi:10.1002/cmdc.201800572 · Cited by 46

Effects of rutin and its derivatives on citrinin production by Monascus aurantiacus Li AS3.4384 in liquid fermentation using different types of media

Huang, Z., Zhang, L., Wang, Y., Gao, H., Li, X., Huang, X., & Huang, T. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.01.109 · Cited by 46

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 896

HMG-CoA reductase inhibitors as potent cholesterol lowering drugs

Tsujita, Y. (1994) · Gordon and Breach Science Publishers eBooks · Cited by 2

Lipid-lowering drugs: discovery and development of HMG-CoA reductase inhibitors.

Tsujita, Y. (1995) · 生体の科学

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

The discovery of the HMG-CoA reductase inhibitors “statins”: A historical perspective

Endo, A. (2001) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.28.6_111